You are viewing the "Richard Harris | NPR" Archives
Infectious disease specialists debate whether it’s better to give the strongest antibiotics all at once for drug-resistant germs or save the most innovative medicines for use as a last resort.
Medical and genetic data from more than a million Americans are now in scientific databases. Some programs hoard the data, while others share widely with scientists, hoping to speed medical discovery.
Ethical concerns aside, the genetic ingredients for human traits are so complex that editing a few embryonic genes is unlikely to have much effect — or achieve the fantasy of enhancing humans.
British doctors report the apparent eradication of HIV from a patient who was undergoing treatment for cancer. It’s only the second time this has been accomplished, despite many attempts.
The U.S. has the highest rates of sexually transmitted disease cases in the industrialized world, say health trackers, with chlamydia, gonorrhea and syphilis reaching 2.3 million cases in 2017.
Many social sciences experiments couldn’t be reproduced in a new study, thus calling into question their findings. The field of social science is pushing hard to improve its scientific rigor.
Formerly considered useless, or maybe a parasite, the stretch of DNA known as LINE-1 actually plays “a key role” in creating an embryo and embryonic stem cells, research shows.
Scientists are training computers to read CT scans and in the hopes they could catch pancreatic cancer early.
Doctors are prescribing fewer drugs to children, especially antibiotics. But use of certain drugs, including ADHD medications, has increased.
Two big studies aim to rigorously test what could be a revolutionary treatment for a common and deadly disease: sepsis. Many doctors are awaiting the results before changing their practice.